About this product

This Piglet Edema Disease Propolis-Adjuvant Vaccine, Inactivated is a crucial veterinary biological product designed to prevent and control edema disease in piglets. Its primary function is to stimulate a robust immune response against the causative agents of edema disease, thereby protecting young pigs from severe illness and mortality. The vaccine's innovative formulation incorporates propolis as an adjuvant, enhancing antigen presentation and eliciting a stronger, more sustained immunity compared to traditional adjuvants. While specific technical specifications and performance characteristics are best discussed directly with the manufacturer, this inactivated vaccine is developed to meet stringent veterinary standards for efficacy and safety. Constructed with high-quality biological components and manufactured under controlled conditions, the vaccine ensures consistent potency and reliability. It is available in standard veterinary packaging suitable for bulk distribution. This product is ideally suited for a wide range of applications within the swine farming industry, including routine vaccination programs on breeding farms and for disease outbreak prevention. Target buyers include veterinary pharmaceutical wholesalers, importers of animal health products, and large-scale pig farming operations seeking effective disease management solutions. Its inactivated nature ensures safety during handling and administration. This vaccine is an excellent choice for international trade buyers due to its proven efficacy in disease prevention, its advanced adjuvant technology, and its contribution to improved animal welfare and farm productivity.